Slc17a3tm2a(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Slc17a3tm2a(KOMP)Wtsi |
Name: |
solute carrier family 17 (sodium phosphate), member 3; targeted mutation 2a, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4362759 |
Gene: |
Slc17a3 Location: Chr13:24023417-24044699 bp, + strand Genetic Position: Chr13, 9.95 cM
|
Alliance: |
Slc17a3tm2a(KOMP)Wtsi page
|
IMPC: |
Slc17a3 gene page |
|
Mutant Cell Lines: |
EPD0217_5_A07, EPD0217_5_B08, EPD0217_5_C07, EPD0217_5_D07, EPD0217_5_E06, EPD0217_5_E08, EPD0217_5_F06, EPD0217_5_F09, EPD0217_5_G09, EPD0217_5_H06 |
Germline Transmission: |
Earliest citation of germline transmission:
J:204812
|
Parent Cell Line: |
JM8.N4 (ES Cell)
|
Strain of Origin: |
C57BL/6N
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Conditional ready, Null/knockout, Reporter) |
Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 24028848 of Chromosome 13 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 24029799. The critical exon(s) is/are thus flanked by loxP sites. A "conditional ready" (floxed) allele can be created by flp recombinase expression in mice carrying this allele. Subsequent cre expression results in a knockout mouse. If cre expression occurs without flp expression, a reporter knockout mouse will be created. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
4 reference(s) |
|